IRIS Accounts Production v24.2.0.383 13853761 director 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh138537612023-01-31138537612024-01-31138537612023-02-012024-01-31138537612022-01-16138537612022-01-172023-01-31138537612023-01-3113853761ns15:EnglandWales2023-02-012024-01-3113853761ns14:PoundSterling2023-02-012024-01-3113853761ns10:Director12023-02-012024-01-3113853761ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3113853761ns10:SmallEntities2023-02-012024-01-3113853761ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3113853761ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3113853761ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3113853761ns10:AbridgedAccounts2023-02-012024-01-3113853761ns10:OrdinaryShareClass12023-02-012024-01-3113853761ns10:RegisteredOffice2023-02-012024-01-3113853761ns5:CurrentFinancialInstruments2024-01-3113853761ns5:CurrentFinancialInstruments2023-01-3113853761ns5:ShareCapital2024-01-3113853761ns5:ShareCapital2023-01-3113853761ns5:RetainedEarningsAccumulatedLosses2024-01-3113853761ns5:RetainedEarningsAccumulatedLosses2023-01-3113853761ns5:ComputerEquipment2023-02-012024-01-3113853761ns10:OrdinaryShareClass12024-01-31
REGISTERED NUMBER: 13853761 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

Pharma RS Ltd

Pharma RS Ltd (Registered number: 13853761)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


Pharma RS Ltd

Company Information
for the Year Ended 31 January 2024







DIRECTOR: Miss R Soma





REGISTERED OFFICE: The Old Doctor's House
74 Grange Road
Dudley
West Midlands
DY1 2AW





REGISTERED NUMBER: 13853761 (England and Wales)

Pharma RS Ltd (Registered number: 13853761)

Abridged Balance Sheet
31 January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,794 603

CURRENT ASSETS
Debtors 11,548 5,132
Cash at bank 32,247 35,626
43,795 40,758
CREDITORS
Amounts falling due within one year 14,787 20,904
NET CURRENT ASSETS 29,008 19,854
TOTAL ASSETS LESS CURRENT
LIABILITIES

30,802

20,457

CAPITAL AND RESERVES
Called up share capital 5 1 1
Retained earnings 30,801 20,456
SHAREHOLDERS' FUNDS 30,802 20,457

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 January 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 23 September 2024 and were signed by:




Miss R Soma - Director


Pharma RS Ltd (Registered number: 13853761)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Pharma RS Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises of current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 February 2023 900
Additions 2,075
At 31 January 2024 2,975
DEPRECIATION
At 1 February 2023 297
Charge for year 884
At 31 January 2024 1,181
NET BOOK VALUE
At 31 January 2024 1,794
At 31 January 2023 603

Pharma RS Ltd (Registered number: 13853761)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
1 Ordinary £1 1 1